Soluble insulin analogs combining rapid- and long-acting hypoglycemic properties – From an efficient E. coli expression system to a pharmaceutical formulation

Diabetes mellitus—advances and challenges in human β-cell proliferation

(2015) Peng Wang et al.   Nature Reviews Endocrinology

The Evolution of Insulin Glargine and its Continuing Contribution to Diabetes Care

(2014) Rolf Hilgenfeld et al.   DRUGS

Insulin Degludec Aspart: The First Co-formulation of Insulin Analogues

(2014) Sanjay Kalra   Diabetes Therapy

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin

(2012) Ib Jonassen et al.   PHARMACEUTICAL RESEARCH

Novel recombinant insulin analogue with flexible C-terminus in B chain. NMR structure of biosynthetic engineered A22G-B31K-B32R human insulin monomer in water/acetonitrile solution

(2011) Piotr Borowicz et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Insulin Therapy for Type 2 Diabetes

(2009) S. G. Swinnen et al.   DIABETES CARE

Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix®30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™observational study

(2009) J. Gumprecht et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

NMR structure of biosynthetic engineered human insulin monomer B31Lys-B32Argin water/acetonitrile solution. Comparison with the solution structure of native human insulin monomer

(2008) Wojciech Bocian et al.   BIOPOLYMERS

New Insulin Analogues and Routes of Delivery

(2008) Paris Roach   CLINICAL PHARMACOKINETICS

Asparagine Deamidation and the Role of Higher Order Protein Structure

(2008) Jenny Rivers et al.   JOURNAL OF PROTEOME RESEARCH